Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 15 most recent Form 4 transactions.
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 431,988 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 75,105 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 500,203 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 167,425 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 138,995 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 99,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 120,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 150,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 488,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | UTENDR | 240,997 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | UTENDR | 110,997 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | UTENDR | 348,431 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 6, 2025 | RLAY | Relay Therapeutics, Inc. | AGRANT◆ | 136,681 | — | — | — | Open the original filing on SEC.gov |